Anbc, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SYUP research report →
About the company
Shanghai Yutong Pharma, Inc. , a company based in Shanghai, China, specializes in the development, manufacturing, and distribution of both traditional Chinese herbal remedies and cutting-edge biological pharmaceuticals within the People's Republic of China. Their diverse product portfolio addresses a wide range of health concerns.
- CEO
- Wei Dong
- IPO
- 2009
- HQ
- Shanghai, CN
Price Chart
- Market Cap
- $15.92K
- P/E
- 0.01
- P/S
- 0.01
- P/B
- 0.01
- EV/EBITDA
- -0.04
- Div Yield
- 0.00%
- Gross Margin
- 49.12%
- Op Margin
- 42.83%
- Net Margin
- 41.14%
- ROE
- 85.99%
- ROIC
- 70.39%
- Revenue
- $3.16M · 10.03%
- Net Income
- $1.30M · 7.15%
- EPS
- $0.02 · -70.94%
- Op Income
- $1.35M
- FCF YoY
- 12034.96%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -6.20
- Avg Volume
- 53.70K
Get TickerSpark's AI analysis on SYUP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SYUP coverage
Recent articles, reports, and earnings notes.
No research on SYUP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SYUP report →Similar companies
Peers in the same neighborhood.